Breaking News, Promotions & Moves

PTC Names Clinical and Translational Ops SVP

Ong brings extensive drug development experience

Author Image

By: Kristin Brooks

Managing Editor, Contract Pharma

Tuyen Ong, M.D., MRCOphth, has been named senior vice president, head of Clinical Development and Translational Research at PTC Therapeutics. Dr. Ong will be responsible for clinical development and operations across all therapeutic areas including genetic disorders, oncology and anti-infectives.   PTC has ongoing Phase III trials underway for Translarna in Duchenne muscular dystrophy and cystic fibrosis, and a proof-of-concept study is currently in preparation for Mucopolysaccharidosis or MPS 1...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters